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この表は Schweichel and Merker: Teratology 1973;7:253（文献４）、Clarke: Anat Embryol 










































































































































































U251TA-RasV12細胞をテトラサイクリン非存在下で１．５日間（Tc(-), Day 1.5）あるいは５日間（Tc(-), 
Day 5）培養した。Tc(+)は U251TA-RasV12細胞をテトラサイクリン存在下で培養したもの。Scale 






イクリン存在下で tumor necrosis factor （TNF）-α （３０ ng /ml）および cycloheximide （２０μg /ml）を加
えて２４時間培養、Tc(+)+TNF+zVADではさらに１００μMの zVAD-fmkの存在下で培養した。広域カス
パーゼ阻害剤 zVAD-fmkは TNF-αによるアポトーシス形態の誘導を抑制するが、Rasにより誘導され











































































































































































































































































































  1 .  Kerr JF, Wyllie AH, Currie AR: Apoptosis: a 
basic biological phenomenon with wide-ranging 
implications in tissue kinetics. Br J Cancer 
1972; 26: 239-257
  2 .  Lockshin RA, Williams CM: Programmed cell 
death-I. Cytology of degeneration in the 
intersegmental muscles of the pernyi silkmoth. 
J Insect Physiol 1965; 11: 123-133
  3 .  Wyllie AH, Kerr JF, Currie AR: Cell death: 
the significance of apoptosis. Int Rev Cytol 
1980; 68:  251-306
  4 .  Schweichel JU, Merker HJ: The morphology 
of various types of cell death in prenatal 
tissues. Teratology 1973; 7: 253-266
  5 . Clarke PG:  Developmental  cell  death: 
morphological diversity and multiple mecha-
nisms. Anat Embryol (Berl) 1990; 181: 195-213
  6 .  Zakeri Z, Bursch W, Tenniswood M, Lockshin 
RA:  Cell  death:  programmed, apoptosis, 
necrosis or other ? Cell Death Differ 1995; 2: 87-
96
  7 . Ellis HM, Horvitz HR: Genetic control of 
programmed cell death in the nematode C. 
elegans. Cell 1986; 44: 817-829
  8 .  Yuan JY, Horvitz HR: The Caenorhabditis 
elegans  genes ced-3 and ced-4  act  cell 
autonomously to cause programmed cell death. 
Dev Biol 1990; 138: 33-41
  9 .  Miura M, Zhu H, Rotello R, Hartwieg EA, 
Yuan J: Induction of apoptosis in fibroblasts by 
IL-1 beta-converting enzyme, a mammalian 
homolog of the C. elegans cell death gene ced-3. 
Cell 1993; 75: 653-660
10.  Hengartner MO, Horvitz HR: C.elegans cell 
survival gene ced-9 encodes a functional 
homolog of the mammalian proto-oncogene bcl-
2. Cell 1994; 76: 665-676
11.  Zou H, Henzel WJ, Liu X, Lutschg A, Wang 
X: Apaf-1, a human protein homologous to C. 
elegans CED-4, participates in cytochrome c-
dependent activation of caspase-3. Cell 1997; 
90: 405-413
12.   Melino G, Knight RA, Green DR: Publica-
tions in cell death: the golden age. Cell Death 
Differ 2001; 8: 1-3
13.  Check E: Worm cast in starring role for Nobel 
Non-apoptoticプログラム細胞死
－94－
prize. Nature 2002; 419: 548-549
14. Marx J: Nobel Prize in Physiology or 
Medicine. Tiny worm takes a star turn. Science 
2002; 298: 526
15. Yuan J, Shaham S, Ledoux S, Ellis HM, 
Horvitz HR: The C. elegans cell death gene ced-
3 encodes a protein similar to mammalian 
interleukin-1 beta-converting enzyme. Cell 
1993; 75: 641-652
16. Alnemri ES, Livingston DJ, Nicholson DW, 
Salvesen G, Thornberry NA, Wong WW, et al.: 
Human ICE/CED-3 protease nomenclature. 
Cell 1996; 87: 171
17. Kumar S, Lavin MF: The ICE family of 
cysteine proteases as effectors of cell death. 
Cell Death Differ 1996; 3: 255-267
18.  Jacobson MD, Weil M, Raff MC: Programmed 
cell death in animal development. Cell 1997; 
88: 347-354
19.  Kitanaka C, Kuchino Y: Caspase-independent 
programmed cell death with necrotic mor-
phology. Cell Death Differ 1999; 6: 508-515
20. Leist M, Jaattela M: Four deaths and a 
funeral:  from  caspases  to   alternative 
mechanisms. Nat Rev Mol Cell Biol 2001; 2: 
589-598
21. Abraham MC, Shaham S: Death without 
caspases, caspases without death. Trends Cell 
Biol 2004;14:184-193
22. Chi S, Kitanaka C, Noguchi K, Mochizuki T, 
Nagashima Y, Shirouzu M, et al.: Oncogenic 
Ras triggers cell suicide through the activation 
of a caspase-independent cell death program in 
human cancer cells. Oncogene 1999; 18: 2281-
2290
23. Pritchard J, Hickman JA: Why does stage 4s 
neuroblastoma regress spontaneously ? Lancet 
1994; 344: 869-870
24. Ballas K, Lyons J, Janssen JW, Bartram CR: 
Incidence  of  ras  gene  mutations  in 
neuroblastoma. Eur J Pediatr 1988; 147: 313-
314
25. Moley JF, Brother MB, Wells SA, Spengler 
BA, Biedler JL, Brodeur GM: Low frequency of 
ras gene mutations in neuroblastomas, pheo-
chromocytomas,　 and　 medullary 　thyroid 　can-
cers. Cancer Res 1991;51:1596-1599
26. Tanaka T, Slamon DJ, Shimada H, Shimoda 
H, Fujisawa T, Ida N, et al.: A significant 
association of Ha-ras p21 in neuroblastoma 
cells with patient prognosis. A retrospective 
study of 103 cases. Cancer 1991;68:1296-1302
27. Tanaka T, Sugimoto T, Sawada T: Prognostic 
discrimination among neuroblastomas accord-
ing to Ha-ras/trk A gene expression: a 
comparison of the profiles of neuroblastomas 
detected clinically and those detected through 
mass screening. Cancer1998;83:1626-1633
28. Koizumi H, Wakisaka M, Nakada K, 
Takakuwa T, Fujioka T, Yamate N, et al.: 
Demonstration of apoptosis in neuroblastoma 
and its relationship to tumour regression. 
Virchows Arch 1995;427:167-173
29. Ikeda H, Hirato J, Akami M, Matsuyama S, 
Suzuki N, Takahashi A, et al.: Bcl-2 oncopro-
tein expression and apoptosis in 
neuroblastoma. J Pediatr Surg 1995;30:805-808
30. Tonini GP, Mazzocco K, di Vinci A, Geido E, 
de Bernardi B, Giaretti W: Evidence of 
apoptosis in neuroblastoma at onset and 
relapse. An analysis of a large series of tumors. 
J Neurooncol 1997;31:209-215
31. Kitanaka C, Kato K, Ijiri R, Sakurada K, 
Tomiyama A, Noguchi K, et al.: Increased Ras 
expression and caspase-independent neuroblas-
toma cell death: possible mechanism  of 
spontaneous neuroblastoma regression. J Natl 
Cancer Inst 2002; 94: 358-368
32. Brooksbank C: RAS, the magician. Nat Rev 
Cancer 2002; 2: 249
33. Jordan J, Galindo MF, Miller RJ: Role of 
calpain- and  interleukin-1    beta    converting 
enzyme-like proteases in the beta-amyloid-
induced death of rat hippocampal neurons in 
culture. J Neurochem 1997; 68: 1612-1621
34. Gschwind M, Huber G: Apoptotic cell death 
北　　中
－95－
induced by beta-amyloid 1-42 peptide is cell 
type dependent. J Neurochem 1995; 65: 292-300
35. Tomlinson BE, Kitchener D: Granulovacuolar 
degeneration of hippocampal pyramidal cells. J 
Pathol 1972; 106: 165-185
36. Okamoto K, Hirai S, Iizuka T, Yanagisawa T, 
Watanabe M: Reexamination of granulova-
cuolar degeneration. Acta Neuropathol (Berl) 
1991; 82: 340-345
37. Jellinger KA, Stadelmann C: Problems of cell 
death in neurodegeneration and Alzheimer's 
Disease. J Alzheimers Dis 2001; 3: 31-40
38. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, 
Michel PP, Marquez J, et al.: Apoptosis and 
autophagy in nigral neurons of patients with 
Parkinson's disease. Histol Histopathol 1997; 
12: 25-31
39. Jellinger KA: Cell death mechanisms in 
Parkinson's disease. J Neural Transm 2000; 
107: 1-29
40. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, 
Greene LA: Expression of A53T mutant but 
not wild-type alpha-synuclein in PC12 cells 
induces alterations of the ubiquitin-dependent 
degradation system, loss of dopamine release, 
and autophagic cell death. J Neurosci 2001; 21: 
9549-9560
41. Kegel KB, Kim M, Sapp E, McIntyre C, 
Castano JG, Aronin N, et al.: Huntingtin 
expression   stimulates   endosomal-lysosomal 
activity, endosome tubulation, and autophagy. J 
Neurosci 2000; 20: 7268-7278
42. Petersen A, Larsen KE, Behr GG, Romero N, 
Przedborski S, Brundin P, et al.: Expanded 
CAG repeats in exon 1 of the Huntington's 
disease gene stimulate dopamine-mediated 
striatal neuron autophagy and degeneration. 
Hum Mol Genet 2001; 10: 1243-1254
43. Turmaine M, Raza A, Mahal A, Mangiarini L, 
Bates GP, Davies SW: Nonapoptotic neurode-
generation in a transgenic mouse model of 
Huntington's disease. Proc Natl Acad Sci U S A 
2000; 97: 8093-8097
44. Migheli A, Atzori C, Piva R, Tortarolo M, 
Girelli M, Schiffer D, et al.:  Lack of apoptosis 
in mice with ALS. Nat Med 1999; 5: 966-967
45. Evert BO, Wullner U, Schulz JB, Weller M, 
Groscurth P, Trottier Y, et al.: High level 
expression of expanded full-length ataxin-3 in 
vitro causes cell death and formation of 
intranuclear inclusions in neuronal cells. Hum 
Mol Genet 1999; 8: 1169-1176
46. Yasuda  S,  Inoue  K,  Hirabayashi  M, 
Higashiyama H, Yamamoto Y, Fuyuhiro H, et 
al.: Triggering of neuronal cell death by 
accumulation of activated SEK1 on nuclear 
polyglutamine aggregations in PML bodies. 
Genes Cells 1999; 4: 743-756
Non-apoptoticプログラム細胞死
－96－
Yamagata Med J 2005；23 (1)：83-96
 Cells comprising multi-cellular organisms harbor intrinsic genetic programs to 
commit “suicide”. The organisms benefit from cellular suicide executed by the 
activation of such genetic programs, which contributes to normal development and 
homeostasis of the organisms, in other words, to disease prevention. Until recently, the 
terms “programmed cell death (PCD)” and “apoptosis” have been used interchangeably. 
However, mounting evidence now unambiguously points to the existence of cell deaths 
genetically regulated yet having morphology and mechanism distinct from apoptosis 
(non-apoptotic PCDs), giving rise to the notion that there is “diversity” in PCD. Direct 
as well as indirect evidence also implicates this non-apoptotic type of PCDs in human 
pathologies such as neurodegenerative diseases and cancer. Here in this article, I 
overview the advances made in this emerging research field of non-apoptotic PCD, 
placing particular emphasis on the idea of “diversity in PCD” as a key to understanding 
pathologies in which PCD plays a critical role.
Key words : programmed cell death, apoptosis, non-apoptotic, autophagic degeneration, 
       Ras
Non apoptotic Programmed Cel Deaths: Existence and
Significance of Programmed Cel Deaths Having
M orphology and M echanism Distinct from A poptosis
Chifumi Kitanaka
ABSTRACT
Department of Molecular Cancer Science,
Yamagata University School of Medicine, Yamagata, Japan
